Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis

Treatment of Murine Colitis by <i>Lactococcus lactis</i> Secreting Interleukin-10

Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513 · see citing works

A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786 · see citing works

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Powrie, F., Correa-Oliveira, R., Mauze, S., & Coffman, R. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.589 · Cited by 613 · see citing works

Role for protease activity in visceral pain in irritable bowel syndrome

Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 1× · see citing works

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B. M., Cox, E., Remon, J. P., & Remaut, E. (2003) · Nature Biotechnology · doi:10.1038/nbt840 · Cited by 545 · see citing works

Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence.

Wiedow, O., Schröder, J. M., Gregory, H., Young, J. A., & Christophers, E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77182-2 · Cited by 433 · see citing works

Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

Cénac, N., Coelho, A., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W., Wallace, J., Hollenberg, M., Bunnett, N., Garcia-Villar, R., et al. (2002) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 386 · see citing works

Role of the microbiota in inflammatory bowel diseases

Nagalingam, N. A., & Lynch, S. V. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21866 · Cited by 315 · see citing works

A Novel Mucosal Vaccine Based on Live Lactococci Expressing E7 Antigen and IL-12 Induces Systemic and Mucosal Immune Responses and Protects Mice against Human Papillomavirus Type 16-Induced Tumors

Bermúdez‐Humarán, L. G., Cortes‐Perez, N. G., Lefèvre, F., Guimarães, V., Rabot, S., Alcocer-González, J. M., Gratadoux, J., Rodrı́guez-Padilla, C., Taméz-Guerra, R. S., Corthier, G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7297 · Cited by 191 · see citing works

CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT

Vergnolle, N. (2005) · Gut · doi:10.1136/gut.2004.048876 · Cited by 166 · see citing works

Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-κB-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli

Henriksen, P. A., Hitt, M., Xing, Z., Wang, J., Haslett, C., Riemersma, R. A., Webb, D. J., Kotelevtsev, Y. V., & Sallenave, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4535 · Cited by 143 · see citing works

Review article: proteinase‐activated receptors — novel signals for gastrointestinal pathophysiology

Vergnolle, N. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00690.x · Cited by 135 · see citing works

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice

Watterlot, L., Rochat, T., Sokol, H., Cherbuy, C., Bouloufa, I., Lefèvre, F., Gratadoux, J., Honvo‐Houeto, E., Chilmonczyk, S., Blugeon, S., et al. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.03.037 · Cited by 134 · see citing works

Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice

Rochat, T., Bermúdez‐Humarán, L. G., Gratadoux, J., Fourage, C., Hoebler, C., Corthier, G., & Langella, P. (2007) · Microbial Cell Factories · doi:10.1186/1475-2859-6-22 · Cited by 132 · see citing works

Secretory Leukocyte Protease Inhibitor and Elafin/Trappin-2

Sallenave, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0095rt · Cited by 130 · see citing works

Modifying the Protease, Antiprotease Pattern by Elafin Overexpression Protects Mice From Colitis

Motta, J., Magne, L., Descamps, D., Rolland, C., Squarzoni–Dale, C., Rousset, P., Martin, L., Cenac, N., Balloy, V., Huerre, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.12.050 · Cited by 130 · see citing works

Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing

Bonnart, C., Deraison, C., Lacroix, M., Uchida, Y., Besson‐Fournier, C., Robin, A., Briot, A., Gonthier, M., Lamant, L., Dubus, P. R., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41440 · Cited by 128 · see citing works

Protease-activated receptors as drug targets in inflammation and pain

Vergnolle, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.004 · Cited by 124 · see citing works

Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn’s disease

Schmid, M., Fellermann, K., Fritz, P., Wiedow, O., Stange, E. F., & Wehkamp, J. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906581 · Cited by 116 · see citing works

In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects

Grimoud, J., Durand, H., Souza, S. D. M. P., MONSAN, P. F., Ouarné, F., Théodorou, V., & Roques, C. G. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.09.007 · Cited by 114 · see citing works

Neutrophil-mediated Activation of Epithelial Protease-Activated Receptors-1 and -2 Regulates Barrier Function and Transepithelial Migration

Chin, A. C., Lee, W. Y., Nusrat, A., Vergnolle, N., & Parkos, C. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5702 · Cited by 106 · see citing works

Protease-activated receptor-2 activation: a major actor in intestinal inflammation

Hyun, E., Andrade‐Gordon, P., Steinhoff, M. S., & Vergnolle, N. (2008) · Gut · doi:10.1136/gut.2008.150722 · Cited by 106 · see citing works

Purifkation and Characterization of Elastase-Specific Inhibitor. Sequence Homology with Mucus Proteinase Inhibitor

Sallenave, J., & RYLE, A. P. (1991) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1991.372.1.13 · Cited by 95 · see citing works

Recombinant lactic acid bacteria as mucosal biotherapeutic agents

Daniel, C., Roussel, Y., Kleerebezem, M., & Pot, B. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.05.002 · Cited by 93 · see citing works

Construction of the mobilizable plasmid pMV158GFP, a derivative of pMV158 that carries the gene encoding the green fluorescent protein

Nieto, C., & Espinosa, M. (2003) · Plasmid · doi:10.1016/s0147-619x(03)00020-9 · Cited by 87 · see citing works

Elafin Prevents Lipopolysaccharide-induced AP-1 and NF-κB Activation via an Effect on the Ubiquitin-Proteasome Pathway

Butler, M. W., Robertson, I., Greene, C. M., O'Neill, S. J., Taggart, C. C., & McElvaney, N. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604844200 · Cited by 83 · see citing works

Therapeutic potential of human elafin

Shaw, L., & Wiedow, O. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391450 · Cited by 80 · see citing works

Elafin and Its Precursor Trappin-2 Still Inhibit Neutrophil Serine Proteinases when They Are Covalently Bound to Extracellular Matrix Proteins by Tissue Transglutaminase

Guyot, N., Zani, M.-L., Maurel, M.-C., Dallet‐Choisy, S., & Moreau, T. (2005) · Biochemistry · doi:10.1021/bi051418i · Cited by 71 · see citing works

Therapeutic Drug Delivery by Genetically Modified Lactococcus lactis

Steidler, L., & Rottiers, P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.031 · Cited by 59 · see citing works

Proteinase-activated Receptor-1 is an Anti-Inflammatory Signal for Colitis Mediated by a Type 2 Immune Response

Cénac, N., Cellars, L., Steinhoff, M. S., Andrade‐Gordon, P., Hollenberg, M. D., Wallace, J. L., Fiorucci, S., & Vergnolle, N. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000177506.71784.bd · Cited by 58 · see citing works

Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): a comparison of different promoters

Sallenave, J., Xing, Z., Simpson, A. J., Graham, F., & Gauldie, J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300610 · Cited by 48 · see citing works

Milk Fat Globule-EGF Factor 8 Is a Critical Protein for Healing of Dextran Sodium Sulfate-Induced Acute Colitis in Mice

Chogle, A. S., Bu, H., Wang, X., Brown, J. B., Chou, P. M., & Tan, X. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00074 · Cited by 46 · see citing works

Pharmabiotic Manipulation of the Microbiota in Gastrointestinal Disorders, from Rationale to Reality

Shanahan, F., & Collins, S. M. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.006 · Cited by 42 · see citing works

Next-generation probiotics: the spectrum from probiotics to live biotherapeutics

O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971 · see citing works

Principles of genetic circuit design

Brophy, J. A. N., & Voigt, C. A. (2014) · Nature Methods · doi:10.1038/nmeth.2926 · Cited by 934 · see citing works

Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis

Cao, F., Jin, L., Gao, Y., Ding, Y., Wen, H., Qian, Z., Zhang, C., Hong, L., Huang, Y., Zhang, J., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01346-x · Cited by 488 · see citing works

Engineering bacteria for diagnostic and therapeutic applications

Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460 · see citing works

Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis

Yu, L. C. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0483-8 · Cited by 404 · see citing works

Microbiota and metabolic diseases

Pascale, A., Marchesi, N., Marelli, C., Coppola, A., Luzi, L., Govoni, S., Giustina, A., & Gazzaruso, C. (2018) · Endocrine · doi:10.1007/s12020-018-1605-5 · Cited by 423 · see citing works

Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets

Santana, P. T., Rosas, S. L. B., Ribeiro, B. E., Marinho, Y., & de Souza, H. S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073464 · Cited by 343 · see citing works

Microbiome therapeutics — Advances and challenges

Mimee, M., Citorik, R. J., & Lu, T. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.032 · Cited by 317 · see citing works

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models

Martín, R., Chain, F., Miquel, S., Lu, J., Gratadoux, J.-J., Sokol, H., Verdu, E. F., Bercik, P., Bermúdez-Humarán, L. G., & Langella, P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440815.76627.64 · Cited by 284 · see citing works

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

Martín, R., Miquel, S., Ulmer, J., Kechaou, N., Langella, P., & Bermúdez‐Humarán, L. G. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-71 · Cited by 269 · see citing works

Gut microbiota, host health, and polysaccharides

Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245 · see citing works

Emerging roles of the microbiome in cancer

Bultman, S. J. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt392 · Cited by 239 · see citing works

Protease inhibition as new therapeutic strategy for GI diseases

Vergnolle, N. (2016) · Gut · doi:10.1136/gutjnl-2015-309147 · Cited by 226 · see citing works

Microbiota effects on cancer: From risks to therapies

Rea, D., Coppola, G., Palma, G., Barbieri, A., Luciano, A., Del Prete, P., Rossetti, S., Berretta, M., Facchini, G., Perdonà, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24681 · Cited by 208 · see citing works

Modulation of bone remodeling by the gut microbiota: A new therapy for osteoporosis

Lyu, Z., Hu, Y., Guo, Y., & Liu, D. (2023) · Bone Research · doi:10.1038/s41413-023-00264-x · Cited by 207 · see citing works

SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase

Zheng, Q., Woehl, J. L., Kitamura, S., Santos‐Martins, D., Smedley, C. J., Li, G., Forli, S., Moses, J. E., Wolan, D. W., & Sharpless, K. B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909972116 · Cited by 200 · see citing works

Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis

Galipeau, H. J., Caminero, A., Turpin, W., Bermudez-Brito, M., Santiago, A., Libertucci, J., Constante, M., Raygoza Garay, J. A., Rueda, G., Armstrong, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.004 · Cited by 190 · see citing works

The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response

Martín, R., Chamignon, C., Mhedbi-Hajri, N., Chain, F., Derrien, M., Escribano-Vázquez, U., Garault, P., Cotillard, A., Pham, H., Chervaux, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41738-5 · Cited by 188 · see citing works

Protectin D1 n-3 DPA and resolvin D5 n-3 DPA are effectors of intestinal protection

Gobbetti, T., Dalli, J., Colas, R. A., Canova, D. F., Aursnes, M., Bonnet, D., Alric, L., Vergnolle, N., Deraison, C., Hansen, T. V., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617290114 · Cited by 170 · see citing works

Engineering lactococci and lactobacilli for human health

Bermúdez‐Humarán, L. G., Aubry, C., Motta, J., Deraison, C., Steidler, L., Vergnolle, N., Chatel, J., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.002 · Cited by 164 · see citing works

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome

Cénac, N., Bautzová, T., Faouder, P. L., Veldhuis, N. A., Poole, D. P., Rolland, C., Bertrand, J., Liedtke, W., Dubourdeau, M., Bertrand‐Michel, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.011 · Cited by 152 · see citing works

Microbiome therapeutics: exploring the present scenario and challenges

Yadav, M., & Chauhan, N. S. (2021) · Gastroenterology report · doi:10.1093/gastro/goab046 · Cited by 157 · see citing works

Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes

Cano‐Garrido, O., Seras‐Franzoso, J., & García‐Fruitós, E. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0313-6 · Cited by 148 · see citing works

Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications

Michon, C., Langella, P., Eijsink, V. G. H., Mathiesen, G., & Chatel, J. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0468-9 · Cited by 140 · see citing works

The microbiome and its potential as a cancer preventive intervention

Bultman, S. J. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.001 · Cited by 134 · see citing works

Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci

Bermúdez‐Humarán, L. G., Motta, J., Aubry, C., Kharrat, P., Martin, L., Sallenave, J., Deraison, C., Vergnolle, N., & Langella, P. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0198-4 · Cited by 128 · see citing works

Indoxyl sulfate induces intestinal barrier injury through IRF1-DRP1 axis-mediated mitophagy impairment

Huang, Y., Zhou, J., Wang, S., Xiong, J., Chen, Y., Liu, Y., Xiao, T., Li, Y., He, T., Li, Y., et al. (2020) · Theranostics · doi:10.7150/thno.45455 · Cited by 128 · see citing works

Epithelial expression and function of trypsin-3 in irritable bowel syndrome

Rolland-Fourcade, C., Denadai-Souza, A., Cirillo, C., Lopez, C., Jaramillo, J. O., Desormeaux, C., Cenac, N., Motta, J.-P., Larauche, M., Taché, Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312094 · Cited by 126 · see citing works

Drinkable in situ-forming tough hydrogels for gastrointestinal therapeutics

Liu, G. W., Pickett, M. J., Kuosmanen, J. L. P., Ishida, K., Madani, W. A. M., White, G. N., Jenkins, J. A., Park, S., Feig, V. R., Jiménez, M., et al. (2024) · Nature Materials · doi:10.1038/s41563-024-01811-5 · Cited by 125 · see citing works

Gut microbiome and anticancer immune response: really hot Sh*t!

Viaud, S., Daillère, R., Boneca, I. G., Lepage, P., Langella, P., Chamaillard, M., Pittet, M. J., Ghiringhelli, F., Trinchieri, G., Goldszmid, R., et al. (2015) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2014.56 · Cited by 123 · see citing works

Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces

Benbouziane, B., Ribelles, P., Aubry, C., Martín, R., Kharrat, P., Riazi, A., Langella, P., & Bermúdez‐Humarán, L. G. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.04.019 · Cited by 115 · see citing works

Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option

Wang, M., Gao, Z., Zhang, Y., & Pan, L. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7557-x · Cited by 112 · see citing works

The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing

Liu, T., Song, X., Khan, S., Li, Y., Guo, Z., Li, C., Wang, S., Dong, W., Liu, W., Wang, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32563 · Cited by 106 · see citing works

Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome

Edwinson, A. L., Yang, L., Peters, S., Hanning, N., Jeraldo, P., Jagtap, P., Simpson, J. B., Yang, T.-Y., Kumar, P., Mehta, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01103-1 · Cited by 105 · see citing works

Endogenous Regulation of Visceral Pain via Production of Opioids by Colitogenic CD4+ T Cells in Mice

Boué, J., Basso, L., Cenac, N., Blanpied, C., Rolli–Derkinderen, M., Neunlist, M., Vergnolle, N., & Dietrich, G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.020 · Cited by 104 · see citing works

Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS

Edogawa, S., Edwinson, A. L., Peters, S. A., Chikkamenahalli, L. L., Sundt, W., Graves, S., Gurunathan, S. V., Breen-Lyles, M., Johnson, S., Dyer, R., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317416 · Cited by 101 · see citing works

Effects in the use of a genetically engineered strain ofLactococcus lactisdelivering in situ IL-10 as a therapy to treat low-grade colon inflammation

Martín, R., Martín, R., Chain, F., Chain, F., Miquel, S., Miquel, S., Natividad, J. M., Natividad, J. M., Sokol, H., Sokol, H., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28549 · Cited by 99 · see citing works

Fecal Serine Protease Profiling in Inflammatory Bowel Diseases

Jablaoui, A., Kriaa, A., Mkaouar, H., Akermi, N., Soussou, S., Wysocka, M., Wołoszyn, D., Amouri, A., Gargouri, A., Maguin, E., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00021 · Cited by 101 · see citing works

Oral delivery of bacteria: Basic principles and biomedical applications

Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 95 · see citing works

Flavonoids as inhibitors of human neutrophil elastase

Jakimiuk, K., Gesek, J., Atanasov, A. G., & Tomczyk, M. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1927006 · Cited by 99 · see citing works

Next generation probiotics for human health: An emerging perspective

Jan, T., Negi, R., Sharma, B., Kumar, S., Singh, S., Rai, A. K., Shreaz, S., Rustagi, S., Chaudhary, N., Kaur, T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35980 · Cited by 95 · see citing works

Engineering Diagnostic and Therapeutic Gut Bacteria

Landry, B. P., & Tabor, J. J. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0020-2017 · Cited by 95 · see citing works

The potential of neutrophil elastase inhibitors as anti-inflammatory therapies

Henriksen, P. A. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000001 · Cited by 95 · see citing works

Light-Sensitive Lactococcus lactis for Microbe–Gut–Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System

Pan, H., Sun, T., Cui, M., Ma, N., Yang, C., Liu, J., Pang, G., Liu, B., Li, L., Zhang, X., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c11536 · Cited by 93 · see citing works

The emerging roles of bacterial proteases in intestinal diseases

Caminero, A., Guzman, M., Libertucci, J., & Lomax, A. E. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2181922 · Cited by 92 · see citing works

Functional Proteomic Profiling of Secreted Serine Proteases in Health and Inflammatory Bowel Disease

Denadai-Souza, A., Bonnart, C., Tapias, N. S., Marcellin, M., Gilmore, B., Alric, L., Bonnet, D., Burlet-Schiltz, O., Hollenberg, M. D., Vergnolle, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26282-y · Cited by 91 · see citing works

Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update

LeBlanc, J. G., Aubry, C., Cortes‐Perez, N. G., de LeBlanc, A. D. M., Vergnolle, N., Langella, P., Azevedo, V., Chatel, J., Miyoshi, A., & Bermúdez‐Humarán, L. G. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12159 · Cited by 86 · see citing works

The Prospects for the Therapeutic Implications of Genetically Engineered Probiotics

Mazhar, S. F., Afzal, M., Almatroudi, A., Munir, S., Ashfaq, U. A., Rasool, M., Raza, H., Munir, H. M. W., Rajoka, M. S. R., & Khurshid, M. (2020) · Journal of Food Quality · doi:10.1155/2020/9676452 · Cited by 85 · see citing works

Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides

Plavec, T. V., & Berlec, A. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09628-y · Cited by 84 · see citing works

Biotechnology of health-promoting bacteria

Douillard, F. P., & de Vos, W. M. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.008 · Cited by 92 · see citing works

Bacterially mediated drug delivery and therapeutics: Strategies and advancements

Wu, L., Bao, F., Li, L., Yin, X., & Hua, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114363 · Cited by 79 · see citing works

Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice

Shigemori, S., Watanabe, T., Kudoh, K., Ihara, M., Nigar, S., Yamamoto, Y., Suda, Y., Sato, T., Kitazawa, H., & Shimosato, T. (2015) · Microbial Cell Factories · doi:10.1186/s12934-015-0378-2 · Cited by 78 · see citing works

Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications

Shamoon, M., Martin, N. M., & O'Brien, C. L. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104344 · Cited by 73 · see citing works

Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders

Galipeau, H. J., Wiepjes, M., Motta, J., Schulz, J. D., Jury, J., Natividad, J. M., Pinto-Sanchez, I., Sinclair, D., Rousset, P., Martín, R., et al. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.48 · Cited by 72 · see citing works

New therapeutic avenues in ulcerative colitis: thinking out of the box

Torres, J., Danese, S., & Colombel, J. (2013) · Gut · doi:10.1136/gutjnl-2012-303959 · Cited by 72 · see citing works

Emerging Frontiers in Microbiome Engineering

Inda, M. E., Broset, E., Lu, T. K., & de la Fuente‐Núñez, C. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.08.007 · Cited by 73 · see citing works

A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor

McCarville, J. L., Dong, J., Caminero, A., Bermudez-Brito, M., Jury, J., Murray, J. A., Duboux, S., Steinmann, M., Delley, M., Tangyu, M., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.01323-17 · Cited by 71 · see citing works

Pharmacological approaches in celiac disease

McCarville, J. L., Caminero, A., & Verdu, E. F. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.002 · Cited by 67 · see citing works

Giardia co-infection promotes the secretion of antimicrobial peptides beta-defensin 2 and trefoil factor 3 and attenuates attaching and effacing bacteria-induced intestinal disease

Mańko, A., Motta, J., Cotton, J. A., Feener, T. D., Oyeyemi, A., Vallance, B. A., Wallace, J. L., & Buret, A. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178647 · Cited by 65 · see citing works

Bacterial interference with canonical NFκB signalling

Johannessen, M., Askarian, F., Sangvik, M., & Sollid, J. E. (2013) · Microbiology · doi:10.1099/mic.0.069369-0 · Cited by 64 · see citing works

Faecal neutrophil elastase-antiprotease balance reflects colitis severity

Barry, R. E., Ruano‐Gallego, D., Radhakrishnan, S. T., Lovell, S., Yu, L., Kotik, O., Glegola-Madejska, I., Tate, E. W., Choudhary, J. S., Williams, H. R. T., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0235-4 · Cited by 63 · see citing works

Active thrombin produced by the intestinal epithelium controls mucosal biofilms

Motta, J., Denadai‐Souza, A., Sagnat, D., Guiraud, L., Edir, A., Bonnart, C., Sebbag, M., Rousset, P., Lapeyre, A., Séguy, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11140-w · Cited by 63 · see citing works

Neutrophil Elastase Causes Tissue Damage That Decreases Host Tolerance to Lung Infection with Burkholderia Species

Sahoo, M., del Barrio, L., Miller, M. A., & Re, F. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004327 · Cited by 62 · see citing works

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology

Buscarinu, M. C., Fornasiero, A., Romano, S., Ferraldeschi, M., Mechelli, R., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01916 · Cited by 62 · see citing works

Immunomodulatory Effects of Lactobacillus Strains: Emphasis On Their Effects on Cancer Cells

Do, A. A., Taherian‐Esfahani, Z., Ghafouri‐Fard, S., Ghafouri-Fard, S., & Motevaseli, E. (2015) · Immunotherapy · doi:10.2217/imt.15.92 · Cited by 61 · see citing works

Synthetic Biology and the Gut Microbiome

Dou, J., & Bennett, M. R. (2017) · Biotechnology Journal · doi:10.1002/biot.201700159 · Cited by 61 · see citing works

Understanding Host-Adherent-InvasiveEscherichia coliInteraction in Crohn’s Disease: Opening Up New Therapeutic Strategies

Agus, A., Massier, S., Darfeuille–Michaud, A., Billard, E., & Barnich, N. (2014) · BioMed Research International · doi:10.1155/2014/567929 · Cited by 60 · see citing works

Interleukin-8 in gastrointestinal inflammation and malignancy: induction and clinical consequences

Beck, P. L., Cotton, J. A., Platnich, J. M., Muruve, D. A., Buret, A. G., & Jijon, H. B. (2016) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s63682 · Cited by 60 · see citing works

Synthetic Biology Approaches in the Development of Engineered Therapeutic Microbes

Kang, M., Choe, D., Kim, K., Cho, B., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228744 · Cited by 58 · see citing works

Exploring the potential impact of probiotic use on drug metabolism and efficacy

Purdel, C. N., Ungurianu, A., Adam-Dima, I., & Margina, D. M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114468 · Cited by 63 · see citing works

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota

Teng, G., Li, H., Liu, Y., Wu, T., Dai, Y., Wang, H., & Wang, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819336 · Cited by 56 · see citing works

Using murine colitis models to analyze probiotics–host interactions

Martín, R., Chain, F., Miquel, S., Motta, J., Vergnolle, N., Sokol, H., & Langella, P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux035 · Cited by 56 · see citing works

Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases

Shigemori, S., & Shimosato, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00022 · Cited by 53 · see citing works

Understanding and Modulating Mammalian-Microbial Communication for Improved Human Health

Mani, S., Boelsterli, U. A., & Redinbo, M. R. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-140007 · Cited by 48 · see citing works

Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health

Levit, R., Cortes‐Perez, N. G., de LeBlanc, A. D. M., Loiseau, J., Aucouturier, A., Langella, P., LeBlanc, J. G., & Bermúdez‐Humarán, L. G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2110821 · Cited by 49 · see citing works

Probiotics and Antibiotics in IBD

Sokol, H. (2014) · Digestive Diseases · doi:10.1159/000367820 · Cited by 48 · see citing works

Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors

Cheng, Y., Li, G., Smedley, C. J., Giel, M., Kitamura, S., Woehl, J. L., Bianco, G., Forli, S., Homer, J. A., Cappiello, J. R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208540119 · Cited by 46 · see citing works

A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation

Zhang, X., Pang, G., Sun, T., Liu, X., Pan, H., Zhang, Y., Liu, J., Chang, J. K., Wang, H., & Liu, D. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122005 · Cited by 46 · see citing works

Advances in understanding of Netherton syndrome and therapeutic implications

Petrova, E., & Hovnanian, A. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1857724 · Cited by 47 · see citing works

Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies

Curciarello, R., Sobande, T. O., Jones, S., Giuffrida, P., Sabatino, A. D., Docena, G. H., MacDonald, T. T., & Kok, K. B. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s234710 · Cited by 45 · see citing works

Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases

Mkaouar, H., Akermi, N., Mariaule, V., Boudebbouze, S., Gaci, N., Szukala, F., Pons, N., Marquez, J., Gargouri, A. F., Maguin, E., et al. (2016) · Microbial Cell Factories · doi:10.1186/s12934-016-0596-2 · Cited by 43 · see citing works

Proteases and small intestinal barrier function in health and disease

Giuffrida, P., Biancheri, P., & MacDonald, T. T. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000042 · Cited by 42 · see citing works

Human airway trypsin-like protease, a serine protease involved in respiratory diseases

Menou, A., Duitman, J., Flajolet, P., Sallenave, J., Mailleux, A., & Crestani, B. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00509.2016 · Cited by 42 · see citing works

Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case

Robert, S., & Steidler, L. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-s1-s11 · Cited by 42 · see citing works

The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase

Caruso, J. A., Akli, S., Pageon, L. R., Hunt, K. K., & Keyomarsi, K. (2014) · Oncogene · doi:10.1038/onc.2014.284 · Cited by 41 · see citing works

Epithelial production of elastase is increased in inflammatory bowel disease and causes mucosal inflammation

Motta, J.-P., Rolland, C., Edir, A., Florence, A.-C., Sagnat, D., Bonnart, C., Rousset, P., Guiraud, L., Quaranta-Nicaise, M., Mas, E., et al. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00375-w · Cited by 40 · see citing works

Digestive Inflammation: Role of Proteolytic Dysregulation

Mariaule, V., Kriaa, A., Soussou, S., Rhimi, S., Boudaya, H., Hernandez, J. L., Maguin, E., Lesner, A., & Rhimi, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062817 · Cited by 40 · see citing works

Probiotics

Mizock, B. A. (2015) · Disease-a-Month · doi:10.1016/j.disamonth.2015.03.011 · Cited by 40 · see citing works

Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions

Tapias, N. S., Denadai‐Souza, A., Rolland-Fourcade, C., Quaranta, M., Blanpied, C., Marcellin, M., Edir, A., Rolland, C., Cirillo, C., Dietrich, G., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab035 · Cited by 39 · see citing works

Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches

Basson, A. R., Lam, M. C., & Cominelli, F. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.002 · Cited by 37 · see citing works

Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation

Kriaa, A., Jablaoui, A., Mkaouar, H., Akermi, N., Maguin, E., & Rhimi, M. (2020) · The FASEB Journal · doi:10.1096/fj.202000031rr · Cited by 38 · see citing works

The Interplay Between Genetic Risk Factors and Proteolytic Dysregulation in the Pathophysiology of Inflammatory Bowel Disease

Tapias, N. S., Vergnolle, N., Denadai‐Souza, A., & Barreau, F. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa033 · Cited by 37 · see citing works

Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse models

Gao, T., Niu, L., Wu, X., Dai, D., Zhou, Y., Liu, M., Wu, K., Yu, Y., Guan, N., & Ye, H. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101513 · Cited by 36 · see citing works

Increased Mucosal Thrombin is Associated with Crohn’s Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation

Motta, J., Palese, S., Giorgio, C., Chapman, K., Denadai‐Souza, A., Rousset, P., Sagnat, D., Guiraud, L., Edir, A., Séguy, C., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa229 · Cited by 36 · see citing works

Mobilization of CD4+ T lymphocytes in inflamed mucosa reduces pain in colitis mice: toward a vaccinal strategy to alleviate inflammatory visceral pain

Basso, L., Boué, J., Augé, C., Deraison, C., Blanpied, C., Cénac, N., Lluel, P., Vergnolle, N., & Dietrich, G. (2017) · Pain · doi:10.1097/j.pain.0000000000001103 · Cited by 35 · see citing works

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Kohl, H. M., Castillo, A., & Ochoa‐Repáraz, J. (2020) · Diseases · doi:10.3390/diseases8030033 · Cited by 35 · see citing works

Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease‐activated receptor 1‐ and protease‐activated receptor 4‐dependent mechanism

Sébert, M., Denadai‐Souza, A., Quaranta, M., Racaud‐Sultan, C., Chabot, S., Lluel, P., Monjotin, N., Alric, L., Portier, G., Kirzin, S., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14430 · Cited by 34 · see citing works

A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum

Mauras, A., Chain, F., Faucheux, A., Ruffié, P., Gontier, S., Ryffel, B., Butel, M., Langella, P., Bermúdez‐Humarán, L. G., & Waligora‐Dupriet, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03075 · Cited by 34 · see citing works

The intestinal microbiome and surgical disease

Krezalek, M. A., Skowron, K. B., Guyton, K. L., Shakhsheer, B. A., Hyoju, S. K., & Alverdy, J. C. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.06.001 · Cited by 32 · see citing works

Metabolic engineering of human gut microbiome: Recent developments and future perspectives

Li, P., Roos, S., Luo, H., Ji, B., & Nielsen, J. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.06.006 · Cited by 33 · see citing works

Elafin—a potential IBD therapy

Greenhill, C. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.223 · Cited by 7 · see citing works

A gardian of gut epithelial barrier from inflammation: the elastase inhibitor ELAFIN

Deraison, C., Jaeger, M.-C., Guiraud, L., Rolland, C., Bellot, A., Rolland, C., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., & Vergnolle, N. (2020) · The FASEB Journal · doi:10.1096/fasebj.2020.34.s1.05293

IBD's bacteria cafeteria

Lou, K.-J. (2012) · Science-Business eXchange · doi:10.1038/scibx.2012.1154

Probiotic Escherichia coli Nissle 1917 Expressing Elafin Protects Against Inflammation and Restores the Gut Microbiota

Teng, G., Li, H., Liu, Y., Wu, T., Dai, Y., Wang, H., & Wang, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.819336 · Cited by 56 · see citing works

Elafin-secreting lactic acid bacteria for treating inflammatory bowel disease (IBD)

(2012) · Science-Business eXchange · doi:10.1038/scibx.2012.1174 · Cited by 1 · see citing works